Abacus Health Products CEO Perry Antelman and Rob Gronkowski to Present at Cowen’s 2nd Annual Boston Cannabis Conference
WOONSOCKET, R.I. & TORONTO--(BUSINESS WIRE)--Nov 6, 2019--
Abacus Health Products, Inc. (CSE:ABCS, OTCQX: ABAHF) (“Abacus” or the “Company”) today announced that it will participate in the 2 nd Annual Boston Cannabis Conference presented by Cowen. The event will be held November 11 th – 13 th 2019 at The Intercontinental Hotel in Boston, MA.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191106005528/en/
Abacus Health Products and Rob Gronkowski to participate in Cowen’s Boston Cannabis Conference (Graphic: Business Wire)
Abacus’ CEO Perry Antelman will participate in a panel discussion on CBD alongside other leading CBD companies. Abacus has also confirmed Cowen CEO Jeffrey Solomon will sit down with Rob Gronkowski for a fireside chat that will highlight Abacus’ recent partnership with the three-time football world champion. Abacus will be available for 1-on-1 meetings throughout the conference.
About Abacus Health Products, Inc.
Abacus is engaged in the development and commercialization of over-the-counter (OTC) registered topical medications with active pharmaceutical ingredients and which contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD from the Cannabis sativa L plant. Abacus’ products are aimed at the rapidly growing markets for topical pain relief and therapeutic skincare and are based on proprietary patent-pending technologies developed by Abacus. Abacus’ formulations combine advanced science with organic and natural ingredients to provide safe relief. Abacus currently offers two lines of products: CBD CLINIC™, marketed to the professional practitioner market, and CBDMEDIC™, marketed to the consumer market. Abacus’ products are offered across the United States and are produced by a contract manufacturer in a cGMP compliant and audited manufacturing facility.
To learn more about Abacus, visit www.abacushp.com
View source version on businesswire.com:https://www.businesswire.com/news/home/20191106005528/en/
CONTACT: For further information:
Hank Hague, Chief Financial Officer
Bill Mitoulas, Investor Relations
KEYWORD: RHODE ISLAND MASSACHUSETTS UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY SPORTS FOOTBALL HEALTH SPECIALTY CONSUMER OTHER CONSUMER RETAIL
SOURCE: Abacus Health Products, Inc.
Copyright Business Wire 2019.
PUB: 11/06/2019 07:57 AM/DISC: 11/06/2019 07:57 AM